I

iBio

IBIO

2.06000
USD
-0.01
(-0.48%)
Market Closed
Volume
6,548
EPS
0
Div Yield
0
P/E
-1
Market Cap
24,618,001
Related Instruments
A
ALT
-0.27000
(-4.24%)
6.10000 USD
A
ARCT
-1.880
(-8.01%)
21.600 USD
B
BCRX
-0.19000
(-2.61%)
7.10000 USD
C
CODX
-0.03000
(-2.59%)
1.13000 USD
I
INO
-0.670
(-6.28%)
10.000 USD
MRNA
-25.020
(-20.99%)
94.160 USD
N
NVAX
-0.250
(-1.95%)
12.560 USD
O
OPK
-0.05000
(-3.50%)
1.38000 USD
V
VXRT
-0.01170
(-1.74%)
0.65890 USD
News

Title: iBio

Sector: Healthcare
Industry: Biotechnology
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.